Table 4 Patient characteristics by tumor histology
From: Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer
Tumor MMP-9 | ||||||
|---|---|---|---|---|---|---|
Squamous cell carcinoma | Adenocarcinoma | |||||
No Expression | Expression | P | No Expression | Expression | P | |
N(%) | N(%) | N(%) | N(%) | |||
Age | 0.464 | 0.160 | ||||
Below median | 64 (49.2) | 25 (55.6) | 57 (55.3) | 45 (45.5) | ||
Above median | 66 (50.8) | 20 (44.4) | 46 (44.7) | 54 (54.5) | ||
Sex | 0.021 | 0.166 | ||||
Male | 121 (93.1) | 36 (80.8) | 41 (39.8) | 49 (49.5) | ||
Female | 9 (6.9) | 9 (20.2) | 62 (60.2) | 50 (50.5) | ||
Stage | 0.021 | 0.006 | ||||
I | 65 (50.0) | 15 (33.4) | 77 (74.7) | 55 (55.6) | ||
II | 49 (37.7) | 19 (42.2) | 15 (14.6) | 24 (24.2) | ||
IIIA | 16 (12.3) | 11 (24.4) | 11 (10.7) | 20 (20.2) | ||
T stage | 0.042 | 0.019 | ||||
T1 | 29 (22.3) | 4 (8.9) | 42 (40.8) | 24 (24.2) | ||
T2 | 75 (57.7) | 29 (64.5) | 55 (53.3) | 67 (67.7) | ||
T3 | 25 (19.2) | 10 (22.2) | 5 (4.9) | 5 (5.1) | ||
T4 | 1 (0.8) | 2 (4.4) | 1 (1.0) | 3 (3.0) | ||
N stage | 0.183 | 0.008 | ||||
N0 | 93 (71.6) | 28 (62.2) | 90 (87.4) | 68 (68.7) | ||
N1 | 31 (23.8) | 13 (28.9) | 3 (2.9) | 14 (14.1) | ||
N2 | 6 (4.6) | 4 (8.9) | 10 (9.7) | 17 (17.2) | ||
Lymphovascular invasion | 0.832 | 0.740 | ||||
No | 111 (85.4) | 39 (86.7) | 94 (91.3) | 89 (89.9) | ||
Yes | 19 (14.6) | 6 (13.3) | 9 (8.7) | 10 (10.1) | ||
Postoperative Treatment | 0.299 | 0.001 | ||||
Chemotherapy | 41 (31.5) | 18 (40.0) | 24 (22.3) | 42 (42.4) | ||
Radiation | 7 (5.4) | 1 (2.2) | 0 | 1 (1.0) | ||
Combination | 10 (7.7) | 6 (13.3) | 7 (6.8) | 13 (13.1) | ||
No treatment | 72 (55.4) | 20 (44.4) | 72 (69.9) | 43 (43.4) | ||